Skip to main content
Our Work

Biomarkers for Traumatic Brain Injury: A Workshop

Completed

Topics

The Forum on Traumatic Brain Injury hosted a 1-day workshop exploring biomarkers to more precisely and objectively diagnose and categorize a suspected TBI, better guide and monitor treatment after injury, and refine future research studies. Workshop discussions addressed such topics as the landscape of TBI biomarker classes, the impact biomarkers can have on various phases of TBI care and research, and key questions and potential opportunities to help advance the field. Video available!

About Past Events

Description

A planning committee of the National Academies of Sciences, Engineering, and Medicine will organize and conduct a public workshop that brings together experts and key stakeholders from academia, government, industry, and non-profit organizations to explore biomarkers for uses such as diagnosis, monitoring, and treatment evaluation of traumatic brain injury (TBI). Presentations and discussions may be designed to:

  • Review the landscape of TBI biomarkers, including blood-based, imaging-based, and other types of relevant physiological markers;
  • Explore clinical needs, challenges, and potential opportunities to advance implementation of FDA-approved biomarkers for TBI;
  • Discuss open research questions, evidence needs, and potential opportunities to inform further biomarker design and validation for TBI.

A proceedings of the presentations and discussions at the workshop will be prepared by a designated rapporteur in accordance with institutional guidelines.

Collaborators

Committee

Member

Member

Member

Member

Member

Member

Member

Member

Katherine Bowman

Staff Officer

Download all bios

Sponsors

Department of Defense

Department of Health and Human Services

Other, Federal

Private: For Profit

Private: Non Profit

Staff

Katherine Bowman

Lead

Subscribe to Email from the National Academies
Keep up with all of the activities, publications, and events by subscribing to free updates by email.